Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Scotland medieval
Biotech

Braveheart files for IPO to support Hengrui-licensed cardio asset

Braveheart Bio isn’t letting Big Pharma take its freedom anytime soon as it aims for a Nasdaq listing to move its phase 3 cardiovascular drug forward.
Will Maddox Jul 15, 2026 1:40pm
Lead Pb on periodic table

With $315M raise, AdvanCell puts radiotherapy pedal to the metal

Jul 15, 2026 10:50am
Panther Rare Pharmacy

De-Risking a Rare Disease Launch Starts with Precision

Brought to you by PANTHERx® Rare Pharmacy
JNJ

J&J axes eye disease gene therapy after key phase 2b readout

Jul 15, 2026 10:26am
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: AdvanCell, Draig & more

Jul 15, 2026 9:00am